Biopharma & Research Growth
Dermatology
AI Synthesis & Market Narrative
The dermatology market sees significant M&A activity for rare skin disease treatments and ongoing biomedical research into aging disorders and antimicrobial solutions for skin-related infections.
Correlated Linguistic Patterns
["rare skin disease drug"
"FDA to approve the medicine"
"premature aging disorders"
"MRSA biofilm-associated implant infections"]
Driving Media Context
HMGA1-HP1β axis regulates premature aging in Hutchinson-Gilford progeria syndrome through chromatin remodeling
Premature aging disorders and normal aging involve changes in chromatin, but the key regulators are not fully understood. Here, the authors show HMGA1 stabil...
Leo Pharma buys rare skin disease drug in $435M deal
Tanabe Pharma has already asked the FDA to approve the medicine for two conditions that cause severe reactions to sunlight.
Michael Burry is Bullish on This Beaten-Down Healthcare Stock. Time to Buy?
Zoetis (NYSE:ZTS) is an animal health company. Michael Burry is long the stock, several media outlets reported, citing his Substack disclosures. The stock is...
When Botox Masks More Than Wrinkles
For most patients, Botox serves a cosmetic purpose. For deaf signers, the same injection can rewrite grammar. Here's why that conversation may belong in the ...
Eradication of MRSA biofilm-associated implant infections by low-immunogenic sustained-release lysostaphin fused to thermosensitive polypeptides
Authors present an antimicrobial characterisation of their elastin-like polypeptide-fused lysostaphin, which offers enhanced stability, low immunogenicity an...
Fargo Center for Dermatology Joins Tareen Dermatology, Expanding North Dakota Presence
Partnership expands Tareen Dermatology to 14 locations across Minnesota, Wisconsin and North Dakota ROSEVILLE, Minn. and FARGO, N.D., Aug. 13, 2026 /PRNewswi...
Aluminum deodorant is a safe option for sweaty armpits – here are the best ones
The best aluminum deodorants block sweat while reducing odor — shop dermatologist-approved options from Secret, Dove, Vanicream and more.
Zoetis Q2 Earnings Call Highlights
Zoetis (NYSE:ZTS) reported second-quarter revenue of $2.5 billion, flat on a reported basis and down 1% organically, as pressure in U.S. companion-animal cat...
Elanco Animal Health Q2 Earnings Call Highlights
Elanco Animal Health (NYSE:ELAN) reported second-quarter 2026 revenue of $1.368 billion, up 10% on a reported basis and 8% organically in constant currency,...
Pregnancy promotes tumor metastasis through adenosine-induced immunosuppressive neutrophils in pre-metastatic microenvironment
Accelerated cancer progression during pregnancy has been previously reported. Here the authors show that adenosine produced in the uterus of pregnant mice pr...
SaaS Metrics